home / press / releases

Menu
  • Search all tables

releases: https://kevinmullin.house.gov/2026/10/30/rep-mullin-urges-fda-to-address-shortage-of-estradiol-patches/

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://kevinmullin.house.gov/2026/10/30/rep-mullin-urges-fda-to-address-shortage-of-estradiol-patches/ Rep. Mullin Urges FDA to Address Shortage of Estradiol Patches 2026-10-30 2026 2026-10 Democrat House CA Kevin Mullin M001225 kevinmullin.house.gov kevinmullin https://kevinmullin.house.gov/category/press_release/ scraper Washington D.C. – In response to a nationwide shortage of estradiol patches and concerns from constituents, Rep. Kevin Mullin (CA-15) wrote to the U.S. Food and Drug Administration (FDA) urging it to take action to ensure steady access to this medicine. Millions of women rely on estradiol patches to treat menopause symptoms – including hot flashes, sleep disturbances, and mood changes – and to preserve their long-term health. Unfortunately, patients across the country have struggled to fill their prescriptions. One national survey found that 44% of women face extreme difficulties or are unable to access their medication. Disruptions in this essential medicine can lead to the sudden and debilitating return of menopause symptoms, and only sporadic access can accelerate bone loss, deteriorate blood vessels, and weaken the skin in the long term. In his letter to the FDA’s Acting Commissioner, Rep. Mullin urged the FDA to include estradiol transdermal patches in the Drug Shortage Database and support efforts to increase supply. Read the full letter here. ### 1 2026-10-30T11:13:31Z 2026-10-30T11:14:27Z
Powered by Datasette · Queries took 0.859ms · Data license: MIT · Data source: dwillis/congress-press